MedTrace Logo

Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India

NCT07290972 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 618

Last updated 2026-02-04

No results posted yet for this study

Summary

This is a combination of retrospective and prospective observational study that will be performed across NCG and other participating centers to report compliance to chemoradiation for cervical cancer. This audit will include patients treated with standard of care treatment, in this case definitive or adjuvant radiation+/- concurrent chemotherapy will be included. Patients recruited in various institutions in prospective clinical trials will not be included. The participating centersthat agree to contribute data will include all registered cases over a 6-month period that have been diagnosed with cervical cancer wherein treatment is planned with radical dose radiation and/or concurrent chemotherapy. Centers that do not have retrospective data of the patients will contribute data of patients registered prospectively over 6 months. Furthermore, any cases referred to the institution for brachytherapy alone will also be included.

As a first step member institutions that participated in guideline development process or provide an agreement to guidelines adherence will be audited. The project will be submitted in institutional ethics committees with memorandum of understanding for anonymized data sharing.

Each of the co-investigators listed from contributing centers will be directly responsible for collecting data contribution and accuracy of data submitted.

Those centres which cannot or do not want to participate will be requested to provide data on only compliance outcomes to treatment for at least of 5 consecutively patients diagnosed with cervical cancer wherein treatment is planned with radical dose radiation and /or concurrent chemotherapy over a period of 6 months.

Conditions

  • Cervical Cancer Screening
  • Gynecologic Cancers
  • Treatment Compliance
  • Chemoradiotherapy

Interventions

OTHER

Not applicable- observational study

Compliance to Cervical Cancer Chemoradiation treatment guidelines

Sponsors & Collaborators

  • Post Graduate Institute of Medical Education and Research, Chandigarh

    collaborator OTHER

  • MNJ Institute of Oncology and Regional Cancer Center

    collaborator OTHER_GOV

  • Christian Medical College, Vellore, India

    collaborator OTHER

  • Tata Memorial Hospital

    lead OTHER_GOV

Principal Investigators

  • Dr. Supriya Chopra, MD · ACTREC, Tata Memorial Centre, Navi Mumbai India

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07290972 on ClinicalTrials.gov